Error loading player: No playable sources found
AC24SUN01
Management of Renal Cell Carcinoma
Date
April 7, 2024
Explore related products in the following collection:
Learning Objectives
- Review new and emerging clinical data on immunotherapy options for the treatment of patients with advanced renal cell carcinoma.
- Strategize the selection of first-line and subsequent-line therapies recommended in the NCCN Guidelines® for Kidney Cancer.
- Discuss the relevance and use of immunotherapy in the adjuvant setting for clear-cell renal cell carcinoma.
Speaker
Michael Serzan, MD
Dana-Farber Cancer Institute
Related Products
Updates in the Management of Neuroblastoma
Use the 'Comments' tab to post questions for the speakers…
Management of Cancer-Related Fatigue
Use the 'Comments' tab to post questions for the speakers…
Capturing Structured Data in the Electronic Health Record
Use the 'Comments' tab to post questions for the speakers…
